HRMY

NASDAQ HEALTHCARE

Harmony Biosciences Holdings

$36.83

$0.70 (+1.94%)

Live quote

52w: $25.90 – $43.49

Loading chart…

P/E Ratio13.26

P/B Ratio2.11

EV/EBITDA—

Debt/Equity—

ROE15.88%

ROIC—

Revenue Growth21.51%

Gross Margin77.16%

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is headquartered in Plymouth Meeting, Pennsylvania.

Own HRMY? Track it here.

Create a free account to add HRMY to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account